New Rochelle, NY, July 17, 2015--Transgender Health, a new peer-reviewed, open access journal launching in 2015 from Mary Ann Liebert, Inc., publishers, will deliver authoritative research and clinical studies exclusively focused on advancing the understanding of the health and healthcare issues and concerns of this unique patient population.
"I want to personally thank Caitlyn Jenner for her courage and frankness which will inspire both patients and medical professionals to recognize the urgent need to deliver the best care to the transgender community," said Mary Ann Liebert, founder, President, and CEO of the company that bears her name. "This journal will move the needle forward in supporting and improving transgender healthcare."
Multidisciplinary in scope, Transgender Health will address the healthcare needs of transgender individuals throughout the lifespan and identify gaps in knowledge as well as priority areas where policy development and research are needed to achieve healthcare parity. Coverage will include disparities in treatment and barriers to care, health services research including cultural competency, mental health and well-being, reproductive health and assisted reproduction, sexually transmitted infections and preventive measures, and best practices, protocols, and guidelines to ensure optimal care.
Transgender Health will be spearheaded by Editor-in-Chief Robert Garofalo, MD, MPH, Professor in Pediatrics-Adolescent Medicine and Preventive Medicine, Northwestern University Feinberg School of Medicine. The Journal will publish under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.
For information on manuscript submission or to sign up for email alerts for Transgender Health, please contact us (email@example.com).
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including LGBT Health, Journal of Women's Health, and AIDS Patient Care and STDs. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.